There is growing evidence to suggest a role for the T cell lymphokine gamma interferon in the regulatory biology of cells of the monocyte/macrophage lineage. IFN-3, induces differentiation of immature myeioid cells along the monocytic pathway and induces or enhances expression of class II HLA antigens during this process (1). Upon exposure to IFN-3,, immature and mature monocytic cells acquire tumoricidal activity (2) and expres~ new receptors for Fc fragments that bind antibody-coated particles, and so initiate phagocytosis. In addition, IFN-~, inhibits monocyte migration in a manner similar to macrophage migration inhibitory factor (3), and inhibits growth of myeloid progenitor cells, particularly those destined to form granulocyte colonies (4). In the present report, we show by immunofluorescence and biochemical identification that IFN-3' induces surface expression of receptors for interleukin 2 (IL-2) by normal human monocytes and by the monocytic and promyelocytic cell lines U937 and HL60. These results suggest the possible involvement of an IL-2 receptor (IL-2R) system on human monocytic cells in monocyte/T cell interaction.
In selected experiments other compounds known to affect differentiation of myeloid/ monocytic cell lines were added for 68 h to U937 and HL60 cultures, including phytohemagglutinin (PHA) leukocyte-conditioned medium (PHA-LCM, 10% vol/vol), recombinant alpha IFN (500 U/mi) (Hoffman-La Roche, Inc., Nutley, NJ), prostaglandin E2 (10 -6 M), retinoic acid (10 -6 M), dimethyl sulfoxide (DMSO) (1.1% vol/vol), 1,25(OH)2 vitamin D3 (10 -s M) (Hoffman-La Roche, Inc.), and cAMP (10 -3 M) (Sigma Chemical Co., St. Louis, MO).
Monoclonal Antibodies. Anti-TAC (6) antibody was a gift from Dr. T. Waldmann. All other antibodies used were produced in the Division of Tumor Immunology, including anti-T3, -T11, -T9, -B1, -B4, and -HLA-DR (9-49), MY4, Mo2, and anti-IL-2R1. The characterization of these antibodies has been previously reviewed (7) .
Immunofluorescence Staining. For one-color staining, 1 × 106 cells were incubated for 30 min at 4°C with the appropriate monoclonal antibody or irrelevant isotype-identical control antibody. If antibodies were not directly fluorescein conjugated, a second incubation was performed for 30 min at 4°C with fluorescein-conjugated goat anti-mouse Ig (Tago, Inc., Burlingame, CA). Washing medium contained 10% human AB serum.
For dual fluorescence studies, IFN-7-treated monocytes were incubated with biotinconjugated anti-Mo2 and a fluoresceinated anti-IL-2Rl (8) . After washing, cells were developed with avidin-conjugated Texas Red (Molecular Probes, Junction City, OR). Cells were analyzed using a dual laser flow cytometer (EPICS V; Coulter Electronics, Hialeah, FL).
lodination, Immunoprecipitation, and SDS-PAGE. U937 cells treated for 60 h with 500 U/ml IFN-3, were externally labeled with 1~5I using the lactoperoxidase-catalyzed method (10) . lmmunoprecipitates with anti-TAC antibody were analyzed by sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis (SDS-PAGE).
Effect of Recombinant IL-2 (rlL-2) on IFN-3,-primed U937 Cells. To determine whether rlL-2R bound to induced IL-2R, the proliferative response of rlFN-~, primed U937 to rlL-2 was tested. U937 cells (1 x 106/ml) were cultured in the presence of 500 U/ml rIFN-7 (concentration of IFN-~, was determined by Biogen). After 48 h, cells were harvested by vigorous pipetting, transferred to 96-well, round-bottom plates (Linbro Chemical Co., Hamden, CT) and cultured for another 48 h in the presence of various dilutions (100, 500, 1,000 U/ml) of rlL-2 at 5 x 104 cells/ml. 12 h before cell harvest some of the cultures were pulsed with 1 ~Ci [3H]thymidine ([~H]TdR). To study adsorption of added rlL2 by IL-2R-expressing U937 cells, we assayed supernatants from nonpulsed cultures for IL-2 using IL-2-dependent T cells as described (9) . The proliferative response to IL-2 was measured as [3H]TdR uptake.
Results and Discussion IL-2 stimulates in vitro proliferation of activated T and B cells (6, 10, 11) by acting through specific cell membrane receptors that have been identified as p60-65 antigens by anti-receptor monoclonal antibodies (6, 8) . We show that not only T and B cells but also normal human peripheral blood monocytes and leukemic cell lines (U937, HL60) capable of monocytic differentiation, express IL-2 surface receptors when exposed to the T cell lymphokine IFN-% Exposure of U937 cells to rIFN-3~ (500 U/ml) induced expression of binding sites for anti-IL-2R antibody 24-48 h after initiation of cultures (Table I) . Identification of these binding sites as IL-2R was confirmed by immunoprecipitation of the same 60-65 kD protein from surface-labeled U937 cells as from PHA-activated T cells (Fig. 1) . Also, rIL-2-induced U937 cells could adsorb IL-2 biological activity but noninduced U937 cells could not (Table II) . The time course of induction of IL-2R paralleled the induction of class II HLA antigens, suggesting de novo synthesis rather than the unmasking of cryptic receptors. In a survey of hematopoietic cells (Table III) Interferon concentration was 500 U/ml. ND, not done. See text for concentrations used. Recovery of viable dells in each fraction was >75%.
restricted to monocytic cells under the conditions used in this study, except for the myeloblast cell line KG-1. IL-2R expression on the myeloid cell lines U937 and HL60 was associated with induction of monocytic differentiation as evidenced by the monocytoid morphology, expression of the monocyte membrane antigen MY4 (Table IV) . Compounds that are known to cause differentiation of HL60 cells into granulocyte cells (DMSO and retinoic acid) failed to induce IL-2R on HL60 and U937 (Table IV) . Similarly, granulocytes (Table III) (Table  IV) . However, other compounds that promote macrophage-like differentiation of U937, such as 1,25(OH)2 vitamin D3, did not cause IL-2R expression on U937 cells (Table IV) (Table III) and two color immunofluorescence (Fig. 2) normal peripheral blood monocyte preparations (99% pure as estimated by morphology and Mo2 staining) could be induced to express IL-2R by recombinant IFN-y (99.4% of cells stained by biotinylated Mo2 antibody, 62.5% double stained by biotinylated Mo2 and fluoresceinated anti-IL-2R 1).
These findings reveal a previously unknown function of IFN-3,. The biological consequences of IL-2R expression by normal monocytes have not been determined, but these results implicate the IL-2/IL-2R system in the control of macrophage differentiation and/or function. It is also possible that macrophage IL-2R expression adsorbs IL-2 at inflammatory sites, and thus serves as a negative feedback loop in T cell/macrophage interaction. S u m m a r y Gamma interferon induced surface expression of interleukin 2 (IL-2) receptors on normal human monocytes and the monocytoid cell lines U937 and HL60. These receptors were detected by anti-IL-2 receptor monoclonal antibodies, and U937 IL-2 receptors were indistinguishable from T lymphocyte IL-2 receptors by immunoprecipitation. Also, U937 IL-2 receptors bound biologically active IL-2. These results suggest a role for monocyte IL-2 receptors in T cell/monocyte interaction during an immune response.
